Item 5.02 Departure of Directors, or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On June 16, 2020, the members of the Board of Directors (the "Board") of BioVie
Inc., a Nevada corporation (the "Company") appointed Dr. Robert Hariri, Mr.
Steve Gorlin and Mr. Sigmund Rogich to serve as members of the Board,
effectively immediately.
Robert J. Hariri, MD, PhD, is the chairman, founder, and chief executive officer
of Celularity, Inc., a leading human cellular therapeutics company. Dr. Hariri
was the founder and CEO of Anthrogenesis Corporation, and after its acquisition
by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr.
Hariri also co-founded the genomic-based health intelligence company, Human
Longevity, Inc. He has served on numerous public boards including Cryoport
(NASDAQ:CYRX). Dr. Hariri pioneered the use of stem cells to treat a range of
life-threatening human diseases and continues to make transformative
contributions in the fields of immuno-oncology and cell therapeutics. He is
widely acknowledged for his discovery of pluripotent stem cells derived from the
human placenta, and assisting with the discovery of the physiological activities
of tumor necrosis factor (TNF). He holds over 170 issued and pending patents and
has authored over 150 published chapters, articles, and abstracts. Over the
years he has garnered numerous awards for contributions to the fields of
biomedicine and aviation.
Mr. Steve Gorlin has founded many biotechnology and pharmaceutical companies
over the past forty-five years, including Hycor Biomedical, Inc. (acquired by
Agilent), Theragenics Corporation (NYSE: TGX), Medicis Pharmaceutical
Corporation (sold to Valeant for approximately $2.6 billion), EntreMed, Inc.
(NASDAQ: ENMD), MRI Interventions (MRIC), DARA BioSciences, Inc. (NASDAQ: DARA),
MiMedx (NASDAQ: MDXG), Medivation, Inc. (NASDAQ: MDVN), sold to Pfizer for $14
billion and Conkwest which became NantKwest (NASDAQ: NK). Mr. Gorlin served for
many years on the Business Advisory Council to the Johns Hopkins School of
Medicine and on The Johns Hopkins BioMedical Engineering Advisory Board. He also
served on the Board of the Andrews Institute. He is currently a member of the
Research Institute Advisory Committee (RIAC) of Massachusetts General Hospital.
He started The Touch Foundation, a nonprofit organization for the blind and was
a principal financial contributor to the founding of Camp Kudzu for diabetic
children.
Mr. Sigmund "Sig" Rogich is President of The Rogich Communications Group and
serves on the Board of Keep Memory Alive, a philanthropic organization which
raises awareness about brain disorders and Alzheimer's disease. Keep Memory
Alive funds clinical trials through Cleveland Clinic's Lou Ruvo Center for Brain
Health to advance new treatments for patients with Alzheimer's, Huntington's and
Parkinson's disease, as well as frontotemporal dementia and multiple sclerosis.
Mr. Rogic was formerly the US Ambassador to Iceland. He has served as a senior
consultant to candidates for the highest office, including Presidents Ronald
Reagan and George H.W.Bush. Mr. Rogich serves on the Board of Directors for many
charitable causes.
On June 17, 2020, the board accepted the resignation of Mr. Jonathan Adams from
his role as director. The resignation was not due to any disagreement on any
matter relating to the Company's operations, policies or practices. The Company
appreciated and thanks Mr. Adams for his years of dedicated service as a
director.
-1-
© Edgar Online, source Glimpses